SW-682 in Advanced Solid Tumors
Recruiting now · Phase 1
Conditions studied: Advanced Solid Tumor, Mesothelioma, Malignant
In brief
This is a first-in-human (FIH), Phase 1a/1b open-label, multicenter, dose escalation and dose expansion study of SW-682 in adult participants with metastatic or unresectable advanced solid tumors with or without Hippo pathway alterations that are refractory to, or have progressed, during or after appropriate prior systemic anticancer therapy, including chemotherapy, immunotherapy, radiation therapy or targeted therapy, or for which no treatment is available, or prior standard of care (SOC) therapy was not tolerated and for which there is no further SOC treatment available. The study includes a Part 1 (Phase 1a) dose escalation phase and a Part 2 (Phase 1b) dose expansion to optimize the dose to be used for further development. All participants will self-administer SW-682 by mouth in 28-day cycles.
Key facts
- Study ID
- NCT06251310
- Run by
- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
- People needed
- 186
- Starts
- 2024-07-31
- Expected to finish
- 2027-01-18
- Last updated by the study team
- 2026-08-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- HonorHealth Research Institute — Scottsdale, Arizona, United States (enrolling)
- USC Norris Comprehensive Cancer Center and Hospital — Los Angeles, California, United States (enrolling)
- UC San Diego Moores Cancer Center — Sacramento, California, United States (enrolling)
- UCLA Hematology-Oncology - Santa Monica — Santa Monica, California, United States (enrolling)
- University Hospital of Cleveland — Cleveland, Ohio, United States (enrolling)
- Oregon Health and Science University, Knight Cancer Institute - Marquam Hill — Portland, Oregon, United States (enrolling)
- Mary Crowley Research Center US Oncology — Dallas, Texas, United States (enrolling)
- U.T. MD Anderson Cancer Center — Houston, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.